SARAH HIGHFILL: Open Payments
NPI 1922777051 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 12 payments from 8 companies in 2025. Trend: 2023 $349 · 2024 $361 · 2025 $327
Food & beverage: $228Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $99 |
| ABBVIE INC. | 3 | $57 |
| Astellas Pharma Global Development | 2 | $49 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $38 |
| Organon LLC | 1 | $26 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| MILLICENT US INC | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Veozah, QULIPTA, NEXPLANON, ACCRUFER, INTRAROSA, Cologuard Collection Kit, UBRELVY.
Industry payments across AR — which companies pay providers there.
